Latest | F'cast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | -24.5% | 5.1% |
ROCE | 84.4% |
Latest | F'cast | |
---|---|---|
P/E | n/a | 40.9 |
PEG | n/a | n/a |
Pr/Revenue | 1.1 | 1.1 |
Pr/Book | 11.8 |
Latest | F'cast | |
---|---|---|
Revenue | 7.2% | 3.3% |
PBT | n/a | n/a |
EPS | n/a | n/a |
DPS | n/a | n/a |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-19 | 5.04 | (3.12) | (12.40)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-20 | 6.74 | (0.65) | (1.50)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-21 | 10.09 | 0.25 | 1.40p | 90.4 | n/a | n/a | n/a | 0.0% |
31-Dec-22 | 12.61 | (0.62) | (1.30)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-23 | 13.52 | (3.46) | (10.10)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-24 | 13.95 | 0.71 | 1.10p | 39.3 | n/a | n/a | n/a | 0.0% |
31-Dec-25 | 15.74 | 1.66 | 5.10p | 8.5 | 0.0 | +364% | 1.50p | 0.0% |
Copyright © 2024 FactSet Research Systems Inc. All rights reserved.
Preliminary Results, Trading Update & Board Change | 01-May-2024 | 07:00 | RNS |
Notice of Results | 30-Apr-2024 | 07:00 | RNS |
COG spin-out Monument Therapeutics accesses ... | 23-Apr-2024 | 07:00 | RNS |
No deals were found in the last 28 days.
Currency | UK Pounds |
Share Price | 43.20p |
Change Today | -1.80p |
% Change | -4.00 % |
52 Week High | 104.00 |
52 Week Low | 43.20 |
Volume | 37,919 |
Shares Issued | 35.15m |
Market Cap | £15.18m |
RiskGrade | 282 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 0 |
Buy | 1 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 1 |
No dividends found |
Time | Volume / Share Price |
16:35 | 9 @ 43.20p |
16:35 | 9 @ 43.20p |
12:13 | 11,104 @ 44.06p |
10:52 | 23,696 @ 44.29p |
10:07 | 845 @ 44.06p |
Chair | Steven John Powell |
CEO | Matthew Stork |
CFO | Stephen Symonds |
You are here: research